List of Tables
Table 1. Global Injectable Cytotoxic Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Injectable Cytotoxic Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Injectable Cytotoxic Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Injectable Cytotoxic Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Injectable Cytotoxic Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Injectable Cytotoxic Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Injectable Cytotoxic Drugs Sales by Region (2020-2025) & (K Units)
Table 8. Global Injectable Cytotoxic Drugs Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Injectable Cytotoxic Drugs Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Injectable Cytotoxic Drugs Sales Share by Manufacturers (2020-2025)
Table 12. Global Injectable Cytotoxic Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Injectable Cytotoxic Drugs Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Injectable Cytotoxic Drugs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Cytotoxic Drugs as of 2024)
Table 16. Global Injectable Cytotoxic Drugs Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Injectable Cytotoxic Drugs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Injectable Cytotoxic Drugs Manufacturing Base and Headquarters
Table 19. Global Injectable Cytotoxic Drugs Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Injectable Cytotoxic Drugs Sales by Type (2020-2025) & (K Units)
Table 23. Global Injectable Cytotoxic Drugs Sales by Type (2026-2031) & (K Units)
Table 24. Global Injectable Cytotoxic Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Injectable Cytotoxic Drugs Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Injectable Cytotoxic Drugs ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Injectable Cytotoxic Drugs Sales by Application (2020-2025) & (K Units)
Table 29. Global Injectable Cytotoxic Drugs Sales by Application (2026-2031) & (K Units)
Table 30. Injectable Cytotoxic Drugs High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Injectable Cytotoxic Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Injectable Cytotoxic Drugs Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Injectable Cytotoxic Drugs ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Injectable Cytotoxic Drugs Growth Accelerators and Market Barriers
Table 37. North America Injectable Cytotoxic Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Injectable Cytotoxic Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Injectable Cytotoxic Drugs Growth Accelerators and Market Barriers
Table 40. Europe Injectable Cytotoxic Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Injectable Cytotoxic Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Injectable Cytotoxic Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Injectable Cytotoxic Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Injectable Cytotoxic Drugs Growth Accelerators and Market Barriers
Table 45. Southeast Asia Injectable Cytotoxic Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Injectable Cytotoxic Drugs Investment Opportunities and Key Challenges
Table 47. Central and South America Injectable Cytotoxic Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Injectable Cytotoxic Drugs Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Injectable Cytotoxic Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Johnson and Johnson Services Corporation Information
Table 51. Johnson and Johnson Services Description and Major Businesses
Table 52. Johnson and Johnson Services Product Models, Descriptions and Specifications
Table 53. Johnson and Johnson Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Johnson and Johnson Services Sales Value Proportion by Product in 2024
Table 55. Johnson and Johnson Services Sales Value Proportion by Application in 2024
Table 56. Johnson and Johnson Services Sales Value Proportion by Geographic Area in 2024
Table 57. Johnson and Johnson Services Injectable Cytotoxic Drugs SWOT Analysis
Table 58. Johnson and Johnson Services Recent Developments
Table 59. Sanofi Corporation Information
Table 60. Sanofi Description and Major Businesses
Table 61. Sanofi Product Models, Descriptions and Specifications
Table 62. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Sanofi Sales Value Proportion by Product in 2024
Table 64. Sanofi Sales Value Proportion by Application in 2024
Table 65. Sanofi Sales Value Proportion by Geographic Area in 2024
Table 66. Sanofi Injectable Cytotoxic Drugs SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Eli Lilly and Company Corporation Information
Table 69. Eli Lilly and Company Description and Major Businesses
Table 70. Eli Lilly and Company Product Models, Descriptions and Specifications
Table 71. Eli Lilly and Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Eli Lilly and Company Sales Value Proportion by Product in 2024
Table 73. Eli Lilly and Company Sales Value Proportion by Application in 2024
Table 74. Eli Lilly and Company Sales Value Proportion by Geographic Area in 2024
Table 75. Eli Lilly and Company Injectable Cytotoxic Drugs SWOT Analysis
Table 76. Eli Lilly and Company Recent Developments
Table 77. Bristol-Myers Squibb Corporation Information
Table 78. Bristol-Myers Squibb Description and Major Businesses
Table 79. Bristol-Myers Squibb Product Models, Descriptions and Specifications
Table 80. Bristol-Myers Squibb Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Bristol-Myers Squibb Sales Value Proportion by Product in 2024
Table 82. Bristol-Myers Squibb Sales Value Proportion by Application in 2024
Table 83. Bristol-Myers Squibb Sales Value Proportion by Geographic Area in 2024
Table 84. Bristol-Myers Squibb Injectable Cytotoxic Drugs SWOT Analysis
Table 85. Bristol-Myers Squibb Recent Developments
Table 86. Roche Corporation Information
Table 87. Roche Description and Major Businesses
Table 88. Roche Product Models, Descriptions and Specifications
Table 89. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Roche Sales Value Proportion by Product in 2024
Table 91. Roche Sales Value Proportion by Application in 2024
Table 92. Roche Sales Value Proportion by Geographic Area in 2024
Table 93. Roche Injectable Cytotoxic Drugs SWOT Analysis
Table 94. Roche Recent Developments
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Major Businesses
Table 97. Novartis Product Models, Descriptions and Specifications
Table 98. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Novartis Recent Developments
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Major Businesses
Table 102. Pfizer Product Models, Descriptions and Specifications
Table 103. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Pfizer Recent Developments
Table 105. Merck KGaA Corporation Information
Table 106. Merck KGaA Description and Major Businesses
Table 107. Merck KGaA Product Models, Descriptions and Specifications
Table 108. Merck KGaA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Merck KGaA Recent Developments
Table 110. Amgen Corporation Information
Table 111. Amgen Description and Major Businesses
Table 112. Amgen Product Models, Descriptions and Specifications
Table 113. Amgen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Amgen Recent Developments
Table 115. AbbVie Corporation Information
Table 116. AbbVie Description and Major Businesses
Table 117. AbbVie Product Models, Descriptions and Specifications
Table 118. AbbVie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. AbbVie Recent Developments
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Major Businesses
Table 122. Sun Pharmaceutical Product Models, Descriptions and Specifications
Table 123. Sun Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Sun Pharmaceutical Recent Developments
Table 125. Kelix Bio Corporation Information
Table 126. Kelix Bio Description and Major Businesses
Table 127. Kelix Bio Product Models, Descriptions and Specifications
Table 128. Kelix Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Kelix Bio Recent Developments
Table 130. Accord Healthcare Corporation Information
Table 131. Accord Healthcare Description and Major Businesses
Table 132. Accord Healthcare Product Models, Descriptions and Specifications
Table 133. Accord Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Accord Healthcare Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Cytotoxic Drugs Product Picture
Figure 2. Global Injectable Cytotoxic Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Alkaloids Product Picture
Figure 4. Metabolites Product Picture
Figure 5. Antibiotics Product Picture
Figure 6. Alkylating agents Product Picture
Figure 7. Others Product Picture
Figure 8. Global Injectable Cytotoxic Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Tumours
Figure 10. Rheumatoid Arthritis
Figure 11. Multiple Sclerosis
Figure 12. Other
Figure 13. Injectable Cytotoxic Drugs Report Years Considered
Figure 14. Global Injectable Cytotoxic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 16. Global Injectable Cytotoxic Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Injectable Cytotoxic Drugs Revenue Market Share by Region (2020-2031)
Figure 18. Global Injectable Cytotoxic Drugs Sales (2020-2031) & (K Units)
Figure 19. Global Injectable Cytotoxic Drugs Sales (CAGR) by Region (2020-2031) (K Units)
Figure 20. Global Injectable Cytotoxic Drugs Sales Market Share by Region (2020-2031)
Figure 21. Top 5 and Top 10 Manufacturers Injectable Cytotoxic Drugs Sales Volume Market Share in 2024
Figure 22. Global Injectable Cytotoxic Drugs Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. Alkaloids Revenue Market Share by Manufacturer in 2024
Figure 25. Metabolites Revenue Market Share by Manufacturer in 2024
Figure 26. Antibiotics Revenue Market Share by Manufacturer in 2024
Figure 27. Alkylating agents Revenue Market Share by Manufacturer in 2024
Figure 28. Others Revenue Market Share by Manufacturer in 2024
Figure 29. Global Injectable Cytotoxic Drugs Sales Market Share by Type (2020-2031)
Figure 30. Global Injectable Cytotoxic Drugs Revenue Market Share by Type (2020-2031)
Figure 31. Global Injectable Cytotoxic Drugs Sales Market Share by Application (2020-2031)
Figure 32. Global Injectable Cytotoxic Drugs Revenue Market Share by Application (2020-2031)
Figure 33. North America Injectable Cytotoxic Drugs Sales YoY (2020-2031) & (K Units)
Figure 34. North America Injectable Cytotoxic Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 35. North America Top 5 Manufacturers Injectable Cytotoxic Drugs Sales Revenue (US$ Million) in 2024
Figure 36. North America Injectable Cytotoxic Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 37. North America Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 38. North America Injectable Cytotoxic Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 39. North America Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 40. US Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 41. Canada Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 42. Mexico Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 43. Europe Injectable Cytotoxic Drugs Sales YoY (2020-2031) & (K Units)
Figure 44. Europe Injectable Cytotoxic Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Europe Top 5 Manufacturers Injectable Cytotoxic Drugs Sales Revenue (US$ Million) in 2024
Figure 46. Europe Injectable Cytotoxic Drugs Sales Volume (K Units) by Type (2020-2031)
Figure 47. Europe Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 48. Europe Injectable Cytotoxic Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 49. Europe Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 50. Germany Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 51. France Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 52. U.K. Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 53. Italy Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 54. Russia Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Injectable Cytotoxic Drugs Sales YoY (2020-2031) & (K Units)
Figure 56. Asia-Pacific Injectable Cytotoxic Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Top 8 Manufacturers Injectable Cytotoxic Drugs Sales Revenue (US$ Million) in 2024
Figure 58. Asia-Pacific Injectable Cytotoxic Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 59. Asia-Pacific Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 60. Asia-Pacific Injectable Cytotoxic Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 61. Asia-Pacific Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 62. Indonesia Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 63. Japan Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 64. South Korea Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 65. China Taiwan Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 66. India Injectable Cytotoxic Drugs Revenue (2020-2031) & (US$ Million)
Figure 67. Central and South America Injectable Cytotoxic Drugs Sales YoY (2020-2031) & (K Units)
Figure 68. Central and South America Injectable Cytotoxic Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 69. Central and South America Top 5 Manufacturers Injectable Cytotoxic Drugs Sales Revenue (US$ Million) in 2024
Figure 70. Central and South America Injectable Cytotoxic Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 71. Central and South America Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 72. Central and South America Injectable Cytotoxic Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 73. Central and South America Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 74. Brazil Injectable Cytotoxic Drugs Revenue (2020-2025) & (US$ Million)
Figure 75. Argentina Injectable Cytotoxic Drugs Revenue (2020-2025) & (US$ Million)
Figure 76. Middle East, and Africa Injectable Cytotoxic Drugs Sales YoY (2020-2031) & (K Units)
Figure 77. Middle East and Africa Injectable Cytotoxic Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 78. Middle East and Africa Top 5 Manufacturers Injectable Cytotoxic Drugs Sales Revenue (US$ Million) in 2024
Figure 79. Middle East and Africa Injectable Cytotoxic Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 80. South America Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 81. Middle East and Africa Injectable Cytotoxic Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 82. Middle East and Africa Injectable Cytotoxic Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 83. GCC Countries Injectable Cytotoxic Drugs Revenue (2020-2025) & (US$ Million)
Figure 84. Turkey Injectable Cytotoxic Drugs Revenue (2020-2025) & (US$ Million)
Figure 85. Egypt Injectable Cytotoxic Drugs Revenue (2020-2025) & (US$ Million)
Figure 86. South Africa Injectable Cytotoxic Drugs Revenue (2020-2025) & (US$ Million)
Figure 87. Injectable Cytotoxic Drugs Industry Chain Mapping
Figure 88. Regional Injectable Cytotoxic Drugs Manufacturing Base Distribution (%)
Figure 89. Global Injectable Cytotoxic Drugs Production Market Share by Region (2020-2031)
Figure 90. Injectable Cytotoxic Drugs Production Process
Figure 91. Regional Injectable Cytotoxic Drugs Production Cost Structure
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
